Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-23-077834
Filing Date
2023-03-23
Accepted
2023-03-23 16:00:58
Documents
9
Period of Report
2023-03-23

Document Format Files

Seq Description Document Type Size
1 6-K d434337d6k.htm 6-K 11866
2 EX-99.1 d434337dex991.htm EX-99.1 18428
3 EX-99.2 d434337dex992.htm EX-99.2 37099
4 EX-99.3 d434337dex993.htm EX-99.3 39982
5 EX-99.4 d434337dex994.htm EX-99.4 44491
6 GRAPHIC g434337g0323203045943.jpg GRAPHIC 2601
7 GRAPHIC g434337g0323203221162.jpg GRAPHIC 2601
8 GRAPHIC g434337g0323203426053.jpg GRAPHIC 2601
9 GRAPHIC g434337g18l69.jpg GRAPHIC 2174
  Complete submission text file 0001193125-23-077834.txt   167394
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 23756116
SIC: 2834 Pharmaceutical Preparations